Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer. [electronic resource]
Producer: 20070628Description: 761-7 p. digitalISSN:- 0923-7534
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Squamous Cell -- chemistry
- Cyclin-Dependent Kinase Inhibitor p27 -- analysis
- ErbB Receptors -- analysis
- Erlotinib Hydrochloride
- Extracellular Signal-Regulated MAP Kinases -- analysis
- Female
- Head and Neck Neoplasms -- chemistry
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Quinazolines -- adverse effects
- Skin -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.